Article
Dallas - Low-dose Propecia (finasteride, Merck), used to treat hair loss, appears to suppress prostate specific antigen (PSA) levels, which could skew results of prostate cancer tests, researchers say.
Dermatology Times November 2024 Print Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Advances in HS treatment with Chris Sayed, MD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Hydroquinone Pigmentation Alternatives
Polynucleotide Therapy Shows Promise in Scar and Burn Management